Alimera Sciences News - ALIM

Company Name	Stock Ticker Symbol	Market	Type
Alimera Sciences Inc	ALIM	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.04	-1.28%	3.09	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
3.08	3.08	3.22	3.09	3.13

more quote information »

Recent News

Date	Time	Source	Heading
9/15/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	08:00	GLOBE	Alimera Sciences to Present at the H.C. Wainwright 25th..
8/23/2023	06:01	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/17/2023	19:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/16/2023	17:17	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/15/2023	16:55	EDGAR2	Form 8-K - Current report
8/11/2023	17:09	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/11/2023	17:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/11/2023	16:17	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	17:26	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/10/2023	16:57	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/10/2023	08:44	EDGAR2	Form 8-K - Current report
8/10/2023	07:30	GLOBE	Alimera Sciences Reports Second Quarter 2023 Results
8/03/2023	16:30	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/03/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/03/2023	16:00	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/02/2023	17:18	EDGAR2	Form 8-K - Current report
8/02/2023	11:43	GLOBE	Alimera Sciences to Report Second Quarter 2023 Financial..
8/01/2023	16:47	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
7/12/2023	16:42	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
6/30/2023	17:12	EDGAR2	Form S-3 - Registration statement under Securities Act of..
6/29/2023	17:23	EDGAR2	Form DEF 14A - Other definitive proxy statements
6/29/2023	17:19	EDGAR2	Form 8-K - Current report
5/24/2023	08:00	GLOBE	Alimera Completes Recruitment for its Landmark NEW DAY Study
5/18/2023	07:00	GLOBE	Alimera Acquires U.S. Commercial Rights to YUTIQ®
5/17/2023	16:05	GLOBE	Alimera Sciences to Host Rescheduled Corporate Update Call..
5/15/2023	07:50	GLOBE	Alimera Sciences Reports First Quarter 2023 Results
5/08/2023	08:00	GLOBE	Alimera Sciences to Report First Quarter 2023 Financial..
4/20/2023	08:00	GLOBE	Alimera Data to be Featured in Scientific Programming at..
4/03/2023	08:00	GLOBE	Alimera Announces Expansion of Agreement with Distribution..
3/31/2023	08:00	GLOBE	Alimera Sciences Announces 2022 Financial Results and..
3/27/2023	08:00	GLOBE	Alimera Improves Capital Structure, Strengthens Balance..
3/24/2023	16:05	GLOBE	Alimera Sciences to Report Fourth Quarter and Full Year 2022..
2/27/2023	08:00	GLOBE	Alimera Appoints Roger Sawhney, M.D. to Its Board of..
2/22/2023	08:00	GLOBE	Alimera Announces Submission of Marketing Authorization..
1/09/2023	08:00	GLOBE	Alimera Sciences Appoints Industry Veteran Russell L...
12/08/2022	08:00	GLOBE	Alimera Sciences Announces Agreement to Extend Amortization..
11/29/2022	08:00	GLOBE	Alimera Highlights Abstracts Regarding Consensus Among US..
11/15/2022	06:35	TRMN	H.C. Wainwright Sticks to Its Buy Rating for Alimera (ALIM)
11/14/2022	07:30	GLOBE	Alimera Sciences Announces Third Quarter 2022 Financial..
11/02/2022	08:00	GLOBE	Alimera Sciences to Report Third Quarter 2022 Financial..
11/01/2022	08:00	GLOBE	Alimera Announces Reimbursement of Uveitis Indication..
10/06/2022	08:00	GLOBE	Paladin Phase 4 Study Confirms ILUVIEN® Patients' Reduced..